CariGenetics Hits Milestone In Cancer Study

CariGenetics reached a milestone in an ongoing cancer study, “surpassing the 25% mark of its regional 1000-men study in Bermuda and Saint Lucia.” A spokesperson said, “CariGenetics, the first genomics company in the world dedicated solely to Caribbean populations, is proud to announce a major milestone in its Caribbean Prostate Cancer Study — surpassing the […]

Go to Source